Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046000 · ClinicalTrials.gov registry record
MRI Evaluation of Graft Maturation Following ACL Reconstruction
A clinical trial, sponsored by Skye Biologics Holdings.
- Not yet
- Registry status
- 10
- Enrollment target
NCT07046000 is a clinical trial that has not yet begun recruiting, run by Skye Biologics Holdings. The registered enrollment target is 10 participants.
The verdict
NCT07046000 has not yet begun recruiting, sponsored by Skye Biologics Holdings.
- NOT YET RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.
Interventions
- DIAGNOSTIC_TEST MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07046000
The ClinicalTrials.gov registry entry for NCT07046000 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skye Biologics Holdings, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT07046000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07046000 about?
NCT07046000 is a clinical study titled "MRI Evaluation of Graft Maturation Following ACL Reconstruction". Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.
What is the current status of trial NCT07046000?
This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2026-08-01. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07046000?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07046000?
This trial is sponsored by Skye Biologics Holdings, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.